Commitments and Contingencies	12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Legal – E&O and Other Considerations As an E&S and Admitted markets intermediary, the Company faces ordinary course of business E&O exposure. The Company also has potential E&O risk if an insurance carrier with which Ryan Specialty placed coverage denies coverage for a claim or pays less than the insured believes is the full amount owed. The Company seeks to resolve, through commercial accommodations, certain matters to limit the economic exposure, including potential legal fees, and reputational risk created by E&O matters as well as disagreements between a carrier and the insured. The Company utilizes insurance to provide protection from E&O liabilities that may arise during the ordinary course of business. Ryan Specialty’s E&O insurance provides aggregate coverage for E&O losses up to $150.0 million in excess of a per claim retention amount of $5.0 million. The Company periodically determines a range of possible outcomes using the best available information that relies, in part, on projecting historical claim data into the future. Loss contingencies of $3.2 million and $4.9 million were recorded for outstanding matters as of December 31, 2025 and 2024, respectively. Loss contingencies exclude the impact of any loss recoveries. The Company recognized the net impact of loss contingencies and any loss recoveries of $4.0 million, $1.8 million, and $6.9 million of E&O expense for the years ended December 31, 2025, 2024, and 2023, respectively, in General and administrative expense on the Consolidated Statements of Income. The historical claim and commercial accommodation data used to project the current estimates may not be indicative of future claim activity. Thus, the estimates could change in the future as more information becomes known, which could materially impact the amounts reported and disclosed herein. During 2022, the Company placed certain insurance policies through a trading partner with the understanding that the policies were underwritten by highly rated insurance capital. The policies were instead underwritten by an insurance carrier that was not considered satisfactory by the Company or the insureds. The Company committed to securing replacement coverage, to the extent commercially available, from highly rated insurance companies on terms substantially similar to the insurance coverage originally agreed upon. As a result of this unusual circumstance, the Company incurred losses arising from the original placements and unpaid covered claims (collectively, the “Replacement Costs”). The Company recognized an estimated loss contingency related to the Replacement Costs of $0.3 million and a loss recovery related to the claim for Replacement Costs of $20.2 million within Accounts payable and accrued liabilities and Other current assets, respectively, on the Consolidated Balance Sheets as of December 31, 2024. During the year ended December 31, 2025, the Company collected $22.1 million from its E&O insurance carriers related to the claim for the Replacement Costs and there was no remaining loss recovery outstanding at December 31, 2025. In the aggregate, the loss contingency and related loss recovery resulted in a $2.5 million expense recognized in the year ended December 31, 2022, and no further expense related to this matter has been recognized since. The Company does not expect any additional Replacement Costs to arise in relation to this matter.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2025

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Legal – E&O and Other Considerations

As an E&S and Admitted markets intermediary, the Company faces ordinary course of business E&O exposure. The

Company also has potential E&O risk if an insurance carrier with which Ryan Specialty placed coverage denies coverage

for a claim or pays less than the insured believes is the full amount owed. The Company seeks to resolve, through

commercial accommodations, certain matters to limit the economic exposure, including potential legal fees, and

reputational risk created by E&O matters as well as disagreements between a carrier and the insured.

The Company utilizes insurance to provide protection from E&O liabilities that may arise during the ordinary course of

business. Ryan Specialty’s E&O insurance provides aggregate coverage for E&O losses up to $150.0 million in excess of a

per claim retention amount of $5.0 million. The Company periodically determines a range of possible outcomes using the

best available information that relies, in part, on projecting historical claim data into the future. Loss contingencies of $3.2

million and $4.9 million were recorded for outstanding matters as of December 31, 2025 and 2024, respectively. Loss

contingencies exclude the impact of any loss recoveries. The Company recognized the net impact of loss contingencies and

any loss recoveries of $4.0 million, $1.8 million, and $6.9 million of E&O expense for the years ended December 31, 2025,

2024, and 2023, respectively, in General and administrative expense on the Consolidated Statements of Income. The

historical claim and commercial accommodation data used to project the current estimates may not be indicative of future

claim activity. Thus, the estimates could change in the future as more information becomes known, which could materially

impact the amounts reported and disclosed herein.

During 2022, the Company placed certain insurance policies through a trading partner with the understanding that the

policies were underwritten by highly rated insurance capital. The policies were instead underwritten by an insurance carrier

that was not considered satisfactory by the Company or the insureds. The Company committed to securing replacement

coverage, to the extent commercially available, from highly rated insurance companies on terms substantially similar to the

insurance coverage originally agreed upon. As a result of this unusual circumstance, the Company incurred losses arising

from the original placements and unpaid covered claims (collectively, the “Replacement Costs”).

The Company recognized an estimated loss contingency related to the Replacement Costs of $0.3 million and a loss

recovery related to the claim for Replacement Costs of $20.2 million within Accounts payable and accrued liabilities and

Other current assets, respectively, on the Consolidated Balance Sheets as of December 31, 2024. During the year ended

December 31, 2025, the Company collected $22.1 million from its E&O insurance carriers related to the claim for the

Replacement Costs and there was no remaining loss recovery outstanding at December 31, 2025. In the aggregate, the loss

contingency and related loss recovery resulted in a $2.5 million expense recognized in the year ended December 31, 2022,

and no further expense related to this matter has been recognized since. The Company does not expect any additional

Replacement Costs to arise in relation to this matter.